StockData
NEUROONE MEDICAL TECHNOLOGIES Corp logo

NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) stock

NMTCNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends September 30
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 11/3079% below fair value
$0.71−0.04 (-5.15%)

Close on Nov 17, 2026Market cap $6.43MP/E –Yield –

Neuroone Medical Technologies operating margin

Operating margin is operating income as a percentage of revenue.

Neuroone Medical Technologies's operating margin for the twelve months ending Jun 30, 2026 was -83.4%. For fiscal 2025 it was -46.5%, against -344.3% the year before. The highest annual figure on record is -46.5% in fiscal 2025.

Annual operating margin

PeriodPeriod endValueChange (pts)
FY2025Sep 30, 2025-46.5%+297.8
FY2024Sep 30, 2024-344.3%+268.1
FY2023Sep 30, 2023-612.3%+5247.8
FY2022Sep 30, 2022-5860.2%−124.3
FY2021Sep 30, 2021-5735.9%−1089.8
FY2014Dec 31, 2014-4646.1%−2637.0
FY2013Dec 31, 2013-2009.0%−518.0
FY2012Dec 31, 2012-1491.1%–

Quarterly operating margin

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange (pts)
Q3 FY2026CQ2 2026Jun 30, 2026-122.9%−11.6
Q2 FY2026CQ1 2026Mar 31, 2026-128.7%+64.5
Q1 FY2026CQ4 2025Dec 31, 2025-59.0%−111.3
Q4 FY2025CQ3 2025Sep 30, 2025-50.0%+984.5
Q3 FY2025CQ2 2025Jun 30, 2025-111.2%+227.1
Q2 FY2025CQ1 2025Mar 31, 2025-193.3%+16.3
Q1 FY2025CQ4 2024Dec 31, 202452.3%+399.1
Q4 FY2024CQ3 2024Sep 30, 2024-1034.5%−607.8
Q3 FY2024CQ2 2024Jun 30, 2024-338.3%+218.9
Q2 FY2024CQ1 2024Mar 31, 2024-209.5%+540.4
Q1 FY2024CQ4 2023Dec 31, 2023-346.8%+1210.5
Q4 FY2023CQ3 2023Sep 30, 2023-426.6%+1608.9
Q3 FY2023CQ2 2023Jun 30, 2023-557.3%+8059.0
Q2 FY2023CQ1 2023Mar 31, 2023-749.9%+7613.9
Q1 FY2023CQ4 2022Dec 31, 2022-1557.3%+6767.1
Q4 FY2022CQ3 2022Sep 30, 2022-2035.5%+3434.8
Q3 FY2022CQ2 2022Jun 30, 2022-8616.3%−1047.0
Q2 FY2022CQ1 2022Mar 31, 2022-8363.8%+4770.5
Q1 FY2022CQ4 2021Dec 31, 2021-8324.4%−5325.6
Q4 FY2021CQ3 2021Sep 30, 2021-5470.3%−3851.7
Q3 FY2021CQ2 2021Jun 30, 2021-7569.3%−1619.3
Q2 FY2021CQ1 2021Mar 31, 2021-13134.3%–
Q1 FY2021CQ4 2020Dec 31, 2020-2998.9%–
Q1 FY2015CQ1 2015Mar 31, 2015-1618.6%–
Q4 FY2014CQ4 2014Dec 31, 2014-5950.0%–

More Neuroone Medical Technologies figures

See a number that looks wrong?